arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Nutex Health Inc.

NUTX
$193.20 ▼ -11.55 (-5.64%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
15 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
86
Health
Excellent
Bullish
auto_awesome

Analytical Summary

Nutex Health Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.2B
Dividend Yield —
Revenue Growth 82.4% ↘
Op. Margin 31.5% ↗
ROIC 56.6% ↘
FCF / Share $38.61 ↗
Trailing P/E 17.4x
Price / Book 4.2x
FCF Yield 20.0%
Debt / Equity 0.09
info Valuation on last close. End-of-day price, Nov 5, 2026.

15-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$875.26M
↑ +82.4% —
Net Income Profit after all expenses
$70.79M
↑ +35.9% —
Operating Margin Operating profit as % of sales
31.5%
↑ +15.6% 87th
FCF / Share Free cash flow per share
$38.61
↑ +842.7% —
Long-Term Debt Long-term obligations
$29.17M
↑ +29.9% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
79
Returns ↓
88
Financial Health →
89
Cash Quality ↑
93

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 15 years · 62 quarters